CPX101 or placebo 120mg Q2W Clinical Trials

2 recruitingBiologic

Phase 11Phase 21

Filters

Status

RecruitingNot yet recruitingEnrolling by invitationActive, not recruiting

Sex

MaleFemale

Your Age

Shows trials you qualify for by age

Phase

Phase 1Phase 2Phase 3Phase 4Early Phase 1Not Applicable

Study Type

InterventionalObservational

Country

United StatesCanadaUnited KingdomAustraliaGermanyFranceSpainItaly

Related Interventions

CPX101 or placebo 160mg Q2W2

Showing 1–2 of 2 trials

Recruiting

Phase 1

Safety, Tolerability, and Pharmacokinetics of a Single or Multiple Ascending Doses of CPX101

Overweight and Obesity

Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.80 enrolled3 locationsNCT06545162

Recruiting

Phase 2

Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects Without Diabetes Mellitus

Overweight and Obesity

Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.240 enrolled1 locationNCT06532578

ClinicalTrialsFinder

Helping patients and researchers find recruiting clinical trials. Updated regularly from ClinicalTrials.gov and ANZCTR.

Browse

Browse Conditions
Browse Drugs
Browse Locations
Browse Institutions
Search Trials
Get Trial Alerts

Resources

Clinical Trial Guides
FAQ
About Us
Contact
Partnerships
ClinicalTrials.gov
ANZCTR

Data Source

Trial data sourced from ClinicalTrials.gov and ANZCTR (Australian New Zealand Clinical Trials Registry)

Updated regularly to reflect the latest trial information

Medical Disclaimer: This site is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making decisions about participating in a clinical trial. Trial information may change; verify details directly with the trial sponsor or at the relevant registry (ClinicalTrials.gov or ANZCTR).

|

Privacy Policy Terms of Service

Data provided by ClinicalTrials.gov & ANZCTR